Philippine-Based Pharmaceutical Importation & Distribution

Built on structured regulatory navigation, reliable logistics, and strong local partnerships. We operate robust distribution channels across hospitals, pharmacies, and healthcare institutions nationwide.

Company Overview

Trusted Market Entry Partner in the Philippines

PPI Pharma Distribution is a Philippine-based pharmaceutical importation and distribution company focused on structured, compliance-driven market entry for international manufacturers.

Whether you're a manufacturer entering the Philippine market or a healthcare institution seeking a dependable pharmaceutical partner, we aim to establish long-term exclusive partnerships and develop strong local distribution channels across hospitals, pharmacies, and healthcare institutions.

Regulatory Authorities

  • Securities and Exchange Commission
  • Bureau of Internal Revenue
  • Food and Drug Administration
  • Bureau of Customs

Warehouse & Distribution Infrastructure

  • Designated warehouse facility
  • Inventory management system
  • Temperature monitoring capability
  • Structured receiving & dispatch
Pharma Prospectus Pharmaceutical Distribution Network
Product Categories

Open for Partnership

We are willing to work under per-product CPR basis for local distribution across the following key categories.

Pharmaceutical Products

  • Antibiotics
  • Anti-diabetics
  • Anti-hypertensives
  • Hospital injectables
  • Renal care products
  • Specialty therapeutics

Medical Devices

  • Dialysis consumables
  • IV infusion sets
  • Surgical disposables
  • Diagnostic kits

Healthcare & Wellness

  • OTC medicines
  • Vitamins & nutraceuticals
  • Baby healthcare products (CPR per product basis)
Why Partner With Us

Structured Market Entry & Compliance

Partnership Model

  • Exclusive Distribution Rights (Philippines)
  • Sole Importer Appointment
  • Authorized Distributor Agreement
  • Dealership Agreement
  • Per-Product CPR Registration & Local Distribution

Market Entry Strategy

  1. Regulatory evaluation per product
  2. CPR filing and approval process
  3. Initial market launch (institutional focus)
  4. Volume scaling based on demand
  5. Long-term territory protection agreement

Commitment to Compliance

  • Full documentation control
  • Transparent regulatory handling
  • Structured procurement planning
  • Long-term manufacturer partnership approach